Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 5Neoplasms 2Cancer Pain 2Prostatic Neoplasms 1Pain, Intractable 1Mucositis 1Leukemia 1Intraoperative Complications 1Digestive System Diseases 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Morphine 6nabiximols 4Oxycodone 3Fentanyl 3Methadone 2Hydromorphone 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1resiniferatoxin 1naloxegol 1Tapentadol 1Sugars 1Standard of Care 1Lidocaine 1Inosine Monophosphate 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Cancer Pain × Hydromorphone × Clear all
NCT04785768 2025-05-22

IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration

Fujian Cancer Hospital

Phase 3 Completed
1,372 enrolled

Cancer Pain

NCT03375515 2021-03-08

PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain

Fujian Cancer Hospital

Phase 3 Completed
214 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡